kidney cancer

Metastatic RCC: High-dose IL-2 ups overall survivalThe survival benefit associated with high-dose IL-2 in metastatic renal cell carcinoma may be better than previously believed.
Selective clamping promising in robot-assisted PNNear-infrared fluorescence-guided selective clamping with indocyanine green fluorescent dye in robot-assisted partial nephrectomy appears to be a promising technique to delineate renal tumor anatomy for the bloodless resection of renal masses while minimizing ischemic damage to the kidney.
Aspirin raises bleeding risk in partial nephrectomyRemaining on preventive antiplatelet therapy with aspirin significantly increases the risk of bleeding complications in patients undergoing partial nephrectomy, according to research presented at the European Association of Urology annual congress in Madrid, Spain.
RT promising in kidney Ca patients with thrombusTwo case studies of stereotactic ablative radiation therapy yielded survival times comparable to those seen with surgical treatment.
Adjuvant therapy fails in locally advanced kidney CaTwo angiogenesis inhibitors that are widely used in metastatic renal cell carcinoma did not improve survival compared with placebo when used as adjuvant treatment, a new study found.
Study: 'Optical biomarkers' may have utility in RCCA novel optical imaging technology is showing promise as a potential diagnostic tool for renal cell carcinoma.
How much do women understand about breast density? And other current researchA research round-up on how much women understand about breast density and the role of lycopene in kidney cancer risk. Plus, NICHD pledges money for research into the placenta.
Best of GU Cancers 2015: Dr. Thrasher’s picks and moreNew, large-scale studies on active surveillance, IMRT complications, and robotic versus open prostatectomy were among the highlights of this year’s Genitourinary Cancers Symposium.
Nonthermal technique promising for small renal tumorsPercutaneous irreversible electroporation is showing promise as a novel minimally invasive approach for treating small renal tumors, according to the experience of urologists at the University of Texas Southwestern Medical Center, Dallas.
New hope for treating deep renal tumors?If further work with irreversible electroporation refines its capacity for discrete tissue ablation deep within the kidney and adjacent to large blood vessels, and especially if larger tumors can be addressed, then this would be a major step forward in the minimally invasive treatment of localized renal cancer.